Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4

Hypertension

Volumn 51, Issue 6, 2008, Pages 1643-1650

  Staessen, Jan A ^a,b   Kuznetsova, Tatiana ^b   Zhang, Haifeng ^b,c   Maillard, Marc ^d   Bochud, Murielle ^d   Hasenkamp, Sandra ^e   Westerkamp, Judith ^e   Richart, Tom ^a,b   Thijs, Lutgarde ^b   Li, Xinli ^c   Brand Herrmann, Stefan Martin ^e   Burnier, Michel ^d   Brand, Eva ^e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c NANJING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Blood pressure; Clinical genetics; Dopamine receptor gene; GRK4; Lithium clearance; Population science; Tubular transport

Indexed keywords

ALDOSTERONE; CREATININE; DOPAMINE 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 4; LITHIUM; RENIN; GRK4 PROTEIN, HUMAN; SODIUM;

ADULT; AGE DISTRIBUTION; ALDOSTERONE URINE LEVEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DISEASE TRANSMISSION; EFFECT SIZE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; KIDNEY CLEARANCE; KIDNEY TUBULE ABSORPTION; MALE; NORMAL HUMAN; PHENOTYPE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROMOTER REGION; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM EXCRETION; SODIUM URINE LEVEL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; FAMILY HEALTH; GENETICS; KIDNEY; METABOLISM; MIDDLE AGED; RENOVASCULAR HYPERTENSION;

ADULT; BLOOD PRESSURE; FAMILY HEALTH; FEMALE; G-PROTEIN-COUPLED RECEPTOR KINASE 4; GENE FREQUENCY; HAPLOTYPES; HUMANS; HYPERTENSION, RENAL; KIDNEY; LITHIUM; MALE; MIDDLE AGED; PHENOTYPE; PROMOTER REGIONS (GENETICS); RECEPTORS, DOPAMINE D1; SODIUM; VARIATION (GENETICS);

EID: 45849130519     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.109611     Document Type: Article

References (37)

1. Felder RA, Jose PA. Mechanism of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol. 2006;2:637-650.
2. Beige J, Bellmann A, Sharma AM, Gessner R. Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension. Am J Hypertens. 2004;17:1184-1187.
3. Grandy DK, Zhou QY, Allen L, Litt R, Magenis RE, Civelli O, Litt M. A human D1 dopamine receptor gene is located on chromosome 5 at q35.1 and identifies an EcoRI RFLP. Am J Hum Genet. 1990;47: 828-834.
4. Wang Z, Armando I, Asico LD, Escano C, Wang X, Lu Q, Felder RA, Schnackenberg CG, Sibley DR, Eisner GM, Jose PA. The elevated blood pressure of human GRKgamma A142V transgenic mice is not associated with increased ROS production. Am J Physiol Heart Circ Physiol. 2007;292:H2083-H2092.
5. Casari G, Barlassina C, Cusi D, Zagato L, Muirhead R, Righetti M, Nembri P, Amar K, Gatti M, Macciardi F, Binelli G, Bianchi G. Association of the alpha-adducin locus with essential hypertension. Hypertension. 1997;25:320-326.
6. Chen W, Li S, Srinivasan SR, Boerwinkle E, Berenson GS. Autosomal genome scan for loci linked to blood pressure levels and trends since childhood. The Bogalusa heart study. Hypertension. 2005;45:954-959.
7. Liu W, Zhao W, Chase GA. Genome scan meta-analysis for hypertension. Am J Hypertens. 2004;17:1100-1106.
8. Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M. Proximal sodium reabsorption. An independent determinant of blood pressure response to salt. Hypertension. 2003;36:631-637.
9. Sleidlerova J, Staessen JA, Maillard M, Nawrot T, Zhang H, Bochud M, Kuznetsova T, Richart T, Van Bortel LM, Struijker-Boudier HA, Manunta P, Burnier M, Fagard R, Filipovský J. Association between arterial properties and renal sodium handling in a general population. Hypertension. 2006;48:609-615.
10. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhäger WH, Herrmann SM, Fagard R, Tizzoni L, Bianchi G. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens. 2001;19:1349-1358.
11. Li Y, Thijs L, Kuznetsova T, Zagato L, Struijker-Boudier H, Bianchi G, Staessen JA. Cardiovascular risk in relation to alpha-addicin Gly460Trp polymorphism and systolic pressure. A prospective population study. Hypertension. 2005;46:527-532.
12. Durr JA, Miller E, Alfrey AC. Lithium clearance derived from the natural trace blood and urine levels. Kidney Intern. 1990;37(suppl 28):S58-S62.
13. Abecasis GR, Cardon LR, Cookson WOC. A general test of association for quantitative traits in nuclear families. Am J Hum Genet. 2000;66: 279-292.
14. Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med. 2001;345:1548-1557.
15. Haney M, Ward AS, Foltin RW, Fischman MW. Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology(Berl). 2001;155:330-337.
16. 1a dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest. 1996;97:2283-2288.
17. Lu Y, Zhu H, Wang X, Snieder H, Huang Y, Harshfield GA, Treiber FA, Dong Y. Effects of dopamine receptor type 1 and Gs protein alpha subunit gene polymorphisms on blood pressure at rest and in response to stress. Am J Hypertens. 2006;19:832-836.
18. Sato M, Soma M, Nakayama T, Kanmatsuse K. Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension. 2000;36:183-186.
19. Baum M, Quigley R. Inhibition of proximal convoluted tubule transport by dopamine. Kidney Intern. 1998;54:1593-1600.
20. + exchanger interactions in the kidney in hypertension. Hypertension. 2000;36:395-399.
21. O'Connell DP, Botkin SJ, Ramos SI, Sibley DR, Ariano MA, Felder RA, Carey RM. Localization of dopamine D1A receptor protein in rat kidneys. Am J Physiol. 1995;268:F1185-F1197.
22. Amenta F, Barili P, Bronzetti E, Ricci A. Dopamine D1-like receptor subtypes in the rat kidney: a microanatomical study. Clin Exp Hypertens. 1999;21:17-23.
23. Ozono R, O'Connell DP, Wang ZQ, Moore AF, Sanada H, Felder RA, Carey RM. Localization of the dopamine D1 receptor protein in the human heart and kidney. Hypertension. 1997;30:725-729.
24. Ragsdale NY, Lynd M, Chevalier RL, Felder RA, Peach MJ, Carey RM. Selective peripheral dopamine-1 receptor stimulation: differential responses to sodium loading and depletion in humans. Hypertension. 1990;15:914-921.
25. Luft FC, Fineberg NS, Sloan RS. Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension. 1982; 4:805-808.
26. Tikhonoff V, Kuznetsova T, Stolarz K, Bianchi G, Casiglia E, Kawecka-Jaszcz K, Nikitin Y, Tizzoni L, Wang JG, Staessen JA. on behalf of the European Project on Genes in Hypertension (EPOGH) Investigators. beta-Adducin polymorphisms, blood pressure and sodium excretion in three European populations. Am J Hypertens. 2003;16:840-846.
27. Lucas LR, Pompei P, McEwen BS. Salt appetite in salt-replete rats: involvement of mesolimbic structures in deoxycorticosterone-induced salt craving behavior. Neuroendocrinology. 2000;71:386-395.
28. Clark JJ, Bernstein IL. A role for D2 but not D1 dopamine receptors in the cross-sensitization between amphetamine and salt appetite. Pharmacol Biochem Behav. 2006;83:277-284.
29. Felder RA, Sanada H, Xu J, Yu P-Y, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong L-JC, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A. 2002;99:3872-3877.
30. Rankin ML, Marinec PS, Cabrera DM, Wang Z, Jose PA, Sibley DR. The D1 dopamine receptor is constituvely phosporylated by G protein-coupled receptor kinase 4. Mol Pharmacol. 2006;69:759-769.
31. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics. 2004;19:233-246.
32. Oppermann M, Diversé-Pierluissi M, Drazner MH, Dyer SL, Freedman NJ, Peppel KC, Lefkowitz RJ. Monoclonal antibodies reveal receptor specificty among G-protein-coupled receptor kinases. Proc Natl Acad Sci USA. 1996;93:7649-7654.
33. Gu D, Su S, Ge D, Chen S, Huang J, Li B, Chen R, Qiang B. Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension. 2006;47:1147-1154.
34. Zhu H, Lu Y, Wang X, Treiber FA, Harshfield GA, Snieder H, Dong Y. The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins. Am J Hypertens. 2006;19:61-66.
35. Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Wanatabe T, Moore JH, Ritchie MD, Williams SM, Pezzullo JC, Sasaki M, Eisner GM, Jose PA, Felder RA. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem. 2006;52:352-360.
36. Lohmueller KE, Wong LJC, Mauney MM, Jiang L, Felder RA, Jose PA, Williams SM. Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure. Ann Hum Genet. 2005;70:27-41.
37. 1 dopamine receptor function. Cardiovasc Hematol Agents Med Chem. 2006;2:369-377.